Literature DB >> 18425822

MRI abnormalities in normal-appearing brain tissue of treated adult PKU patients.

Xiao-Qi Ding1, Jens Fiehler, Brigitte Kohlschütter, Oliver Wittkugel, Ulrich Grzyska, Hermann Zeumer, Kurt Ullrich.   

Abstract

PURPOSE: To detect possible subclinical pathological brain changes a study on adult phenylketonuria (PKU) patients by using quantitative MRI methods was performed, since neuropsychological and cognitive deficits in treated patients with PKU have not yet been shown to correlate clearly with the brain lesions identified by conventional MRI.
MATERIALS AND METHODS: Eight subjects, four PKU patients with well-documented dietary treatment and four age- and sex-matched adult controls, underwent MRI, including a triple echo sequence and a diffusion tensor imaging sequence. Brain maps of T2 relaxation time (T2), relative proton density (PD), and fractional anisotropy (FA) as well as apparent diffusion coefficient (ADC) were derived for each subject. T2, PD, FA, and ADC were measured in 22 predefined regions of gray matter (GM) and white matter (WM) on the corresponding maps, and compared with those of four age-matched healthy adult controls.
RESULTS: In addition to a prolonged T2 value measured in affected WM, as expected, we observed a significant shortening of the T2 relaxation time and reduction of ADC in normal-appearing brain tissue and an increased proton density in both GM and WM of the patients. No differences were observed in FA values between controls and patients.
CONCLUSION: Repeatedly reduced T2 relaxation time, ADC, and increased proton density without changes in FA indicate a higher cell-packing density in normal-appearing brain without changes in the directedness of fibers. These structural changes may be related to neuropsychological and cognitive deficits in treated PKU patients. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18425822     DOI: 10.1002/jmri.21289

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  21 in total

1.  Executive strategic processing during verbal fluency performance in children with phenylketonuria.

Authors:  Pia Banerjee; Dorothy K Grange; Robert D Steiner; Desirée A White
Journal:  Child Neuropsychol       Date:  2010-12-07       Impact factor: 2.500

2.  HAX1 mutations causing severe congenital neuropenia and neurological disease lead to cerebral microstructural abnormalities documented by quantitative MRI.

Authors:  Kaan Boztug; Xiao-Qi Ding; Hans Hartmann; Lena Ziesenitz; Alejandro A Schäffer; Jana Diestelhorst; Dietmar Pfeifer; Giridharan Appaswamy; Sonja Kehbel; Thorsten Simon; Abdullah Al Jefri; Heinrich Lanfermann; Christoph Klein
Journal:  Am J Med Genet A       Date:  2010-12       Impact factor: 2.802

Review 3.  New frontiers in neuroimaging applications to inborn errors of metabolism.

Authors:  Morgan J Prust; Andrea L Gropman; Natalie Hauser
Journal:  Mol Genet Metab       Date:  2011-06-30       Impact factor: 4.797

4.  Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria.

Authors:  Huiling Peng; Dawn Peck; Desirée A White; Shawn E Christ
Journal:  J Inherit Metab Dis       Date:  2013-09-17       Impact factor: 4.982

5.  Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria.

Authors:  Anna Hood; Jo Ann V Antenor-Dorsey; Jerrel Rutlin; Tamara Hershey; Joshua S Shimony; Robert C McKinstry; Dorothy K Grange; Shawn E Christ; Robert Steiner; Desiree A White
Journal:  Mol Genet Metab       Date:  2014-11-13       Impact factor: 4.797

Review 6.  Patterns of brain injury in inborn errors of metabolism.

Authors:  Andrea L Gropman
Journal:  Semin Pediatr Neurol       Date:  2012-12       Impact factor: 1.636

Review 7.  Pharmacological MRI (phMRI) of the Human Central Nervous System.

Authors:  H Lanfermann; C Schindler; J Jordan; N Krug; P Raab
Journal:  Clin Neuroradiol       Date:  2015-09-02       Impact factor: 3.649

8.  White matter integrity and executive abilities in individuals with phenylketonuria.

Authors:  Jo Ann V Antenor-Dorsey; Tamara Hershey; Jerrel Rutlin; Joshua S Shimony; Robert C McKinstry; Dorothy K Grange; Shawn E Christ; Desirée A White
Journal:  Mol Genet Metab       Date:  2013-04-06       Impact factor: 4.797

9.  Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria.

Authors:  Renzo Manara; Alessandro P Burlina; Valentina Citton; Mario Ermani; Francesco Vespignani; Carla Carollo; Alberto B Burlina
Journal:  Neuroradiology       Date:  2009-08-04       Impact factor: 2.804

10.  Quantitative MRI shows cerebral microstructural damage in hemolytic-uremic syndrome patients with severe neurological symptoms but no changes in conventional MRI.

Authors:  Karin Weissenborn; Eva Bültmann; Frank Donnerstag; Anja M Giesemann; Friedrich Götz; Hans Worthmann; Meike Heeren; Jan Kielstein; Anke Schwarz; Heinrich Lanfermann; Xiao-Qi Ding
Journal:  Neuroradiology       Date:  2013-04-05       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.